Global Vaccine Development Service Market Growth (Status and Outlook) 2025-2031
The global Vaccine Development Service market size is predicted to grow from US$ million in 2025 to US$ million in 2031; it is expected to grow at a CAGR of %from 2025 to 2031.
Vaccine Development Service refers to the process of developing vaccines against various diseases. It involves the research, testing, and production of vaccines to prevent or treat specific infections or diseases. This service typically includes activities such as identifying target antigens, conducting preclinical studies, performing clinical trials, obtaining regulatory approvals, and scaling up production for widespread distribution. Vaccine development services are usually provided by pharmaceutical companies, research institutions, and government agencies to address public health needs and combat infectious diseases.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
LPI (LP Information)' newest research report, the “Vaccine Development Service Industry Forecast” looks at past sales and reviews total world Vaccine Development Service sales in 2024, providing a comprehensive analysis by region and market sector of projected Vaccine Development Service sales for 2025 through 2031. With Vaccine Development Service sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Vaccine Development Service industry.
This Insight Report provides a comprehensive analysis of the global Vaccine Development Service landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyses the strategies of leading global companies with a focus on Vaccine Development Service portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Vaccine Development Service market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Vaccine Development Service and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Vaccine Development Service.
This report presents a comprehensive overview, market shares, and growth opportunities of Vaccine Development Service market by product type, application, key players and key regions and countries.
Segmentation by Type:
Vaccine Development Service refers to the process of developing vaccines against various diseases. It involves the research, testing, and production of vaccines to prevent or treat specific infections or diseases. This service typically includes activities such as identifying target antigens, conducting preclinical studies, performing clinical trials, obtaining regulatory approvals, and scaling up production for widespread distribution. Vaccine development services are usually provided by pharmaceutical companies, research institutions, and government agencies to address public health needs and combat infectious diseases.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
LPI (LP Information)' newest research report, the “Vaccine Development Service Industry Forecast” looks at past sales and reviews total world Vaccine Development Service sales in 2024, providing a comprehensive analysis by region and market sector of projected Vaccine Development Service sales for 2025 through 2031. With Vaccine Development Service sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Vaccine Development Service industry.
This Insight Report provides a comprehensive analysis of the global Vaccine Development Service landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyses the strategies of leading global companies with a focus on Vaccine Development Service portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Vaccine Development Service market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Vaccine Development Service and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Vaccine Development Service.
This report presents a comprehensive overview, market shares, and growth opportunities of Vaccine Development Service market by product type, application, key players and key regions and countries.
Segmentation by Type:
- Therapeutic
- Prophylactic
- Other
- Enterprise
- Government
- Americas
- United States
- Canada
- Mexico
- Brazil
- APAC
- China
- Japan
- Korea
- Southeast Asia
- India
- Australia
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Middle East & Africa
- Egypt
- South Africa
- Israel
- Turkey
- GCC Countries
- WuXi AppTec
- Charles River Laboratories
- Creative Biolabs
- Creative Biostructure
- PPD
- Merck
- Sartorius
- Eurofins Scientific
- Statens Serum Institut
- Thermo Fisher Scientific
- TRANSVAC
- Azenta US
1 SCOPE OF THE REPORT
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Vaccine Development Service Market Size (2020-2031)
2.1.2 Vaccine Development Service Market Size CAGR by Region (2020 VS 2024 VS 2031)
2.1.3 World Current & Future Analysis for Vaccine Development Service by Country/Region (2020, 2024 & 2031)
2.2 Vaccine Development Service Segment by Type
2.2.1 Therapeutic
2.2.2 Prophylactic
2.2.3 Other
2.3 Vaccine Development Service Market Size by Type
2.3.1 Vaccine Development Service Market Size CAGR by Type (2020 VS 2024 VS 2031)
2.3.2 Global Vaccine Development Service Market Size Market Share by Type (2020-2025)
2.4 Vaccine Development Service Segment by Application
2.4.1 Enterprise
2.4.2 Government
2.5 Vaccine Development Service Market Size by Application
2.5.1 Vaccine Development Service Market Size CAGR by Application (2020 VS 2024 VS 2031)
2.5.2 Global Vaccine Development Service Market Size Market Share by Application (2020-2025)
3 VACCINE DEVELOPMENT SERVICE MARKET SIZE BY PLAYER
3.1 Vaccine Development Service Market Size Market Share by Player
3.1.1 Global Vaccine Development Service Revenue by Player (2020-2025)
3.1.2 Global Vaccine Development Service Revenue Market Share by Player (2020-2025)
3.2 Global Vaccine Development Service Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 VACCINE DEVELOPMENT SERVICE BY REGION
4.1 Vaccine Development Service Market Size by Region (2020-2025)
4.2 Global Vaccine Development Service Annual Revenue by Country/Region (2020-2025)
4.3 Americas Vaccine Development Service Market Size Growth (2020-2025)
4.4 APAC Vaccine Development Service Market Size Growth (2020-2025)
4.5 Europe Vaccine Development Service Market Size Growth (2020-2025)
4.6 Middle East & Africa Vaccine Development Service Market Size Growth (2020-2025)
5 AMERICAS
5.1 Americas Vaccine Development Service Market Size by Country (2020-2025)
5.2 Americas Vaccine Development Service Market Size by Type (2020-2025)
5.3 Americas Vaccine Development Service Market Size by Application (2020-2025)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Vaccine Development Service Market Size by Region (2020-2025)
6.2 APAC Vaccine Development Service Market Size by Type (2020-2025)
6.3 APAC Vaccine Development Service Market Size by Application (2020-2025)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 EUROPE
7.1 Europe Vaccine Development Service Market Size by Country (2020-2025)
7.2 Europe Vaccine Development Service Market Size by Type (2020-2025)
7.3 Europe Vaccine Development Service Market Size by Application (2020-2025)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Vaccine Development Service by Region (2020-2025)
8.2 Middle East & Africa Vaccine Development Service Market Size by Type (2020-2025)
8.3 Middle East & Africa Vaccine Development Service Market Size by Application (2020-2025)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 GLOBAL VACCINE DEVELOPMENT SERVICE MARKET FORECAST
10.1 Global Vaccine Development Service Forecast by Region (2026-2031)
10.1.1 Global Vaccine Development Service Forecast by Region (2026-2031)
10.1.2 Americas Vaccine Development Service Forecast
10.1.3 APAC Vaccine Development Service Forecast
10.1.4 Europe Vaccine Development Service Forecast
10.1.5 Middle East & Africa Vaccine Development Service Forecast
10.2 Americas Vaccine Development Service Forecast by Country (2026-2031)
10.2.1 United States Market Vaccine Development Service Forecast
10.2.2 Canada Market Vaccine Development Service Forecast
10.2.3 Mexico Market Vaccine Development Service Forecast
10.2.4 Brazil Market Vaccine Development Service Forecast
10.3 APAC Vaccine Development Service Forecast by Region (2026-2031)
10.3.1 China Vaccine Development Service Market Forecast
10.3.2 Japan Market Vaccine Development Service Forecast
10.3.3 Korea Market Vaccine Development Service Forecast
10.3.4 Southeast Asia Market Vaccine Development Service Forecast
10.3.5 India Market Vaccine Development Service Forecast
10.3.6 Australia Market Vaccine Development Service Forecast
10.4 Europe Vaccine Development Service Forecast by Country (2026-2031)
10.4.1 Germany Market Vaccine Development Service Forecast
10.4.2 France Market Vaccine Development Service Forecast
10.4.3 UK Market Vaccine Development Service Forecast
10.4.4 Italy Market Vaccine Development Service Forecast
10.4.5 Russia Market Vaccine Development Service Forecast
10.5 Middle East & Africa Vaccine Development Service Forecast by Region (2026-2031)
10.5.1 Egypt Market Vaccine Development Service Forecast
10.5.2 South Africa Market Vaccine Development Service Forecast
10.5.3 Israel Market Vaccine Development Service Forecast
10.5.4 Turkey Market Vaccine Development Service Forecast
10.6 Global Vaccine Development Service Forecast by Type (2026-2031)
10.7 Global Vaccine Development Service Forecast by Application (2026-2031)
10.7.1 GCC Countries Market Vaccine Development Service Forecast
11 KEY PLAYERS ANALYSIS
11.1 WuXi AppTec
11.1.1 WuXi AppTec Company Information
11.1.2 WuXi AppTec Vaccine Development Service Product Offered
11.1.3 WuXi AppTec Vaccine Development Service Revenue, Gross Margin and Market Share (2020-2025)
11.1.4 WuXi AppTec Main Business Overview
11.1.5 WuXi AppTec Latest Developments
11.2 Charles River Laboratories
11.2.1 Charles River Laboratories Company Information
11.2.2 Charles River Laboratories Vaccine Development Service Product Offered
11.2.3 Charles River Laboratories Vaccine Development Service Revenue, Gross Margin and Market Share (2020-2025)
11.2.4 Charles River Laboratories Main Business Overview
11.2.5 Charles River Laboratories Latest Developments
11.3 Creative Biolabs
11.3.1 Creative Biolabs Company Information
11.3.2 Creative Biolabs Vaccine Development Service Product Offered
11.3.3 Creative Biolabs Vaccine Development Service Revenue, Gross Margin and Market Share (2020-2025)
11.3.4 Creative Biolabs Main Business Overview
11.3.5 Creative Biolabs Latest Developments
11.4 Creative Biostructure
11.4.1 Creative Biostructure Company Information
11.4.2 Creative Biostructure Vaccine Development Service Product Offered
11.4.3 Creative Biostructure Vaccine Development Service Revenue, Gross Margin and Market Share (2020-2025)
11.4.4 Creative Biostructure Main Business Overview
11.4.5 Creative Biostructure Latest Developments
11.5 PPD
11.5.1 PPD Company Information
11.5.2 PPD Vaccine Development Service Product Offered
11.5.3 PPD Vaccine Development Service Revenue, Gross Margin and Market Share (2020-2025)
11.5.4 PPD Main Business Overview
11.5.5 PPD Latest Developments
11.6 Merck
11.6.1 Merck Company Information
11.6.2 Merck Vaccine Development Service Product Offered
11.6.3 Merck Vaccine Development Service Revenue, Gross Margin and Market Share (2020-2025)
11.6.4 Merck Main Business Overview
11.6.5 Merck Latest Developments
11.7 Sartorius
11.7.1 Sartorius Company Information
11.7.2 Sartorius Vaccine Development Service Product Offered
11.7.3 Sartorius Vaccine Development Service Revenue, Gross Margin and Market Share (2020-2025)
11.7.4 Sartorius Main Business Overview
11.7.5 Sartorius Latest Developments
11.8 Eurofins Scientific
11.8.1 Eurofins Scientific Company Information
11.8.2 Eurofins Scientific Vaccine Development Service Product Offered
11.8.3 Eurofins Scientific Vaccine Development Service Revenue, Gross Margin and Market Share (2020-2025)
11.8.4 Eurofins Scientific Main Business Overview
11.8.5 Eurofins Scientific Latest Developments
11.9 Statens Serum Institut
11.9.1 Statens Serum Institut Company Information
11.9.2 Statens Serum Institut Vaccine Development Service Product Offered
11.9.3 Statens Serum Institut Vaccine Development Service Revenue, Gross Margin and Market Share (2020-2025)
11.9.4 Statens Serum Institut Main Business Overview
11.9.5 Statens Serum Institut Latest Developments
11.10 Thermo Fisher Scientific
11.10.1 Thermo Fisher Scientific Company Information
11.10.2 Thermo Fisher Scientific Vaccine Development Service Product Offered
11.10.3 Thermo Fisher Scientific Vaccine Development Service Revenue, Gross Margin and Market Share (2020-2025)
11.10.4 Thermo Fisher Scientific Main Business Overview
11.10.5 Thermo Fisher Scientific Latest Developments
11.11 TRANSVAC
11.11.1 TRANSVAC Company Information
11.11.2 TRANSVAC Vaccine Development Service Product Offered
11.11.3 TRANSVAC Vaccine Development Service Revenue, Gross Margin and Market Share (2020-2025)
11.11.4 TRANSVAC Main Business Overview
11.11.5 TRANSVAC Latest Developments
11.12 Azenta US
11.12.1 Azenta US Company Information
11.12.2 Azenta US Vaccine Development Service Product Offered
11.12.3 Azenta US Vaccine Development Service Revenue, Gross Margin and Market Share (2020-2025)
11.12.4 Azenta US Main Business Overview
11.12.5 Azenta US Latest Developments
12 RESEARCH FINDINGS AND CONCLUSION
LIST OFTABLES
Table 1. Vaccine Development Service Market Size CAGR by Region (2020 VS 2024 VS 2031) & ($ millions)
Table 2. Vaccine Development Service Annual Sales CAGR by Country/Region (2020, 2024 & 2031) & ($ millions)
Table 3. Major Players ofTherapeutic
Table 4. Major Players of Prophylactic
Table 5. Major Players of Other
Table 6. Vaccine Development Service Market Size CAGR byType (2020 VS 2024 VS 2031) & ($ millions)
Table 7. Global Vaccine Development Service Market Size byType (2020-2025) & ($ millions)
Table 8. Global Vaccine Development Service Market Size Market Share byType (2020-2025)
Table 9. Vaccine Development Service Market Size CAGR by Application (2020 VS 2024 VS 2031) & ($ millions)
Table 10. Global Vaccine Development Service Market Size by Application (2020-2025) & ($ millions)
Table 11. Global Vaccine Development Service Market Size Market Share by Application (2020-2025)
Table 12. Global Vaccine Development Service Revenue by Player (2020-2025) & ($ millions)
Table 13. Global Vaccine Development Service Revenue Market Share by Player (2020-2025)
Table 14. Vaccine Development Service Key Players Head office and Products Offered
Table 15. Vaccine Development Service Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
Table 16. New Products and Potential Entrants
Table 17. Mergers & Acquisitions, Expansion
Table 18. Global Vaccine Development Service Market Size by Region (2020-2025) & ($ millions)
Table 19. Global Vaccine Development Service Market Size Market Share by Region (2020-2025)
Table 20. Global Vaccine Development Service Revenue by Country/Region (2020-2025) & ($ millions)
Table 21. Global Vaccine Development Service Revenue Market Share by Country/Region (2020-2025)
Table 22. Americas Vaccine Development Service Market Size by Country (2020-2025) & ($ millions)
Table 23. Americas Vaccine Development Service Market Size Market Share by Country (2020-2025)
Table 24. Americas Vaccine Development Service Market Size byType (2020-2025) & ($ millions)
Table 25. Americas Vaccine Development Service Market Size Market Share byType (2020-2025)
Table 26. Americas Vaccine Development Service Market Size by Application (2020-2025) & ($ millions)
Table 27. Americas Vaccine Development Service Market Size Market Share by Application (2020-2025)
Table 28. APAC Vaccine Development Service Market Size by Region (2020-2025) & ($ millions)
Table 29. APAC Vaccine Development Service Market Size Market Share by Region (2020-2025)
Table 30. APAC Vaccine Development Service Market Size byType (2020-2025) & ($ millions)
Table 31. APAC Vaccine Development Service Market Size by Application (2020-2025) & ($ millions)
Table 32. Europe Vaccine Development Service Market Size by Country (2020-2025) & ($ millions)
Table 33. Europe Vaccine Development Service Market Size Market Share by Country (2020-2025)
Table 34. Europe Vaccine Development Service Market Size byType (2020-2025) & ($ millions)
Table 35. Europe Vaccine Development Service Market Size by Application (2020-2025) & ($ millions)
Table 36. Middle East & Africa Vaccine Development Service Market Size by Region (2020-2025) & ($ millions)
Table 37. Middle East & Africa Vaccine Development Service Market Size byType (2020-2025) & ($ millions)
Table 38. Middle East & Africa Vaccine Development Service Market Size by Application (2020-2025) & ($ millions)
Table 39. Key Market Drivers & Growth Opportunities of Vaccine Development Service
Table 40. Key Market Challenges & Risks of Vaccine Development Service
Table 41. Key IndustryTrends of Vaccine Development Service
Table 42. Global Vaccine Development Service Market SizeForecast by Region (2026-2031) & ($ millions)
Table 43. Global Vaccine Development Service Market Size Market ShareForecast by Region (2026-2031)
Table 44. Global Vaccine Development Service Market SizeForecast byType (2026-2031) & ($ millions)
Table 45. Global Vaccine Development Service Market SizeForecast by Application (2026-2031) & ($ millions)
Table 46. WuXi AppTec Details, CompanyType, Vaccine Development Service Area Served and Its Competitors
Table 47. WuXi AppTec Vaccine Development Service Product Offered
Table 48. WuXi AppTec Vaccine Development Service Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 49. WuXi AppTec Main Business
Table 50. WuXi AppTec Latest Developments
Table 51. Charles River Laboratories Details, CompanyType, Vaccine Development Service Area Served and Its Competitors
Table 52. Charles River Laboratories Vaccine Development Service Product Offered
Table 53. Charles River Laboratories Vaccine Development Service Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 54. Charles River Laboratories Main Business
Table 55. Charles River Laboratories Latest Developments
Table 56. Creative Biolabs Details, CompanyType, Vaccine Development Service Area Served and Its Competitors
Table 57. Creative Biolabs Vaccine Development Service Product Offered
Table 58. Creative Biolabs Vaccine Development Service Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 59. Creative Biolabs Main Business
Table 60. Creative Biolabs Latest Developments
Table 61. Creative Biostructure Details, CompanyType, Vaccine Development Service Area Served and Its Competitors
Table 62. Creative Biostructure Vaccine Development Service Product Offered
Table 63. Creative Biostructure Vaccine Development Service Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 64. Creative Biostructure Main Business
Table 65. Creative Biostructure Latest Developments
Table 66. PPD Details, CompanyType, Vaccine Development Service Area Served and Its Competitors
Table 67. PPD Vaccine Development Service Product Offered
Table 68. PPD Vaccine Development Service Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 69. PPD Main Business
Table 70. PPD Latest Developments
Table 71. Merck Details, CompanyType, Vaccine Development Service Area Served and Its Competitors
Table 72. Merck Vaccine Development Service Product Offered
Table 73. Merck Vaccine Development Service Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 74. Merck Main Business
Table 75. Merck Latest Developments
Table 76. Sartorius Details, CompanyType, Vaccine Development Service Area Served and Its Competitors
Table 77. Sartorius Vaccine Development Service Product Offered
Table 78. Sartorius Vaccine Development Service Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 79. Sartorius Main Business
Table 80. Sartorius Latest Developments
Table 81. Eurofins Scientific Details, CompanyType, Vaccine Development Service Area Served and Its Competitors
Table 82. Eurofins Scientific Vaccine Development Service Product Offered
Table 83. Eurofins Scientific Vaccine Development Service Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 84. Eurofins Scientific Main Business
Table 85. Eurofins Scientific Latest Developments
Table 86. Statens Serum Institut Details, CompanyType, Vaccine Development Service Area Served and Its Competitors
Table 87. Statens Serum Institut Vaccine Development Service Product Offered
Table 88. Statens Serum Institut Vaccine Development Service Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 89. Statens Serum Institut Main Business
Table 90. Statens Serum Institut Latest Developments
Table 91.ThermoFisher Scientific Details, CompanyType, Vaccine Development Service Area Served and Its Competitors
Table 92.ThermoFisher Scientific Vaccine Development Service Product Offered
Table 93.ThermoFisher Scientific Vaccine Development Service Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 94.ThermoFisher Scientific Main Business
Table 95.ThermoFisher Scientific Latest Developments
Table 96.TRANSVAC Details, CompanyType, Vaccine Development Service Area Served and Its Competitors
Table 97.TRANSVAC Vaccine Development Service Product Offered
Table 98.TRANSVAC Vaccine Development Service Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 99.TRANSVAC Main Business
Table 100.TRANSVAC Latest Developments
Table 101. Azenta US Details, CompanyType, Vaccine Development Service Area Served and Its Competitors
Table 102. Azenta US Vaccine Development Service Product Offered
Table 103. Azenta US Vaccine Development Service Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 104. Azenta US Main Business
Table 105. Azenta US Latest Developments
LIST OFFIGURES
Figure 1. Vaccine Development Service Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global Vaccine Development Service Market Size Growth Rate (2020-2031) ($ millions)
Figure 6. Vaccine Development Service Sales by Geographic Region (2020, 2024 & 2031) & ($ millions)
Figure 7. Vaccine Development Service Sales Market Share by Country/Region (2024)
Figure 8. Vaccine Development Service Sales Market Share by Country/Region (2020, 2024 & 2031)
Figure 9. Global Vaccine Development Service Market Size Market Share byType in 2024
Figure 10. Vaccine Development Service in Enterprise
Figure 11. Global Vaccine Development Service Market: Enterprise (2020-2025) & ($ millions)
Figure 12. Vaccine Development Service in Government
Figure 13. Global Vaccine Development Service Market: Government (2020-2025) & ($ millions)
Figure 14. Global Vaccine Development Service Market Size Market Share by Application in 2024
Figure 15. Global Vaccine Development Service Revenue Market Share by Player in 2024
Figure 16. Global Vaccine Development Service Market Size Market Share by Region (2020-2025)
Figure 17. Americas Vaccine Development Service Market Size 2020-2025 ($ millions)
Figure 18. APAC Vaccine Development Service Market Size 2020-2025 ($ millions)
Figure 19. Europe Vaccine Development Service Market Size 2020-2025 ($ millions)
Figure 20. Middle East & Africa Vaccine Development Service Market Size 2020-2025 ($ millions)
Figure 21. Americas Vaccine Development Service Value Market Share by Country in 2024
Figure 22. United States Vaccine Development Service Market Size Growth 2020-2025 ($ millions)
Figure 23. Canada Vaccine Development Service Market Size Growth 2020-2025 ($ millions)
Figure 24. Mexico Vaccine Development Service Market Size Growth 2020-2025 ($ millions)
Figure 25. Brazil Vaccine Development Service Market Size Growth 2020-2025 ($ millions)
Figure 26. APAC Vaccine Development Service Market Size Market Share by Region in 2024
Figure 27. APAC Vaccine Development Service Market Size Market Share byType (2020-2025)
Figure 28. APAC Vaccine Development Service Market Size Market Share by Application (2020-2025)
Figure 29. China Vaccine Development Service Market Size Growth 2020-2025 ($ millions)
Figure 30. Japan Vaccine Development Service Market Size Growth 2020-2025 ($ millions)
Figure 31. South Korea Vaccine Development Service Market Size Growth 2020-2025 ($ millions)
Figure 32. Southeast Asia Vaccine Development Service Market Size Growth 2020-2025 ($ millions)
Figure 33. India Vaccine Development Service Market Size Growth 2020-2025 ($ millions)
Figure 34. Australia Vaccine Development Service Market Size Growth 2020-2025 ($ millions)
Figure 35. Europe Vaccine Development Service Market Size Market Share by Country in 2024
Figure 36. Europe Vaccine Development Service Market Size Market Share byType (2020-2025)
Figure 37. Europe Vaccine Development Service Market Size Market Share by Application (2020-2025)
Figure 38. Germany Vaccine Development Service Market Size Growth 2020-2025 ($ millions)
Figure 39.France Vaccine Development Service Market Size Growth 2020-2025 ($ millions)
Figure 40. UK Vaccine Development Service Market Size Growth 2020-2025 ($ millions)
Figure 41. Italy Vaccine Development Service Market Size Growth 2020-2025 ($ millions)
Figure 42. Russia Vaccine Development Service Market Size Growth 2020-2025 ($ millions)
Figure 43. Middle East & Africa Vaccine Development Service Market Size Market Share by Region (2020-2025)
Figure 44. Middle East & Africa Vaccine Development Service Market Size Market Share byType (2020-2025)
Figure 45. Middle East & Africa Vaccine Development Service Market Size Market Share by Application (2020-2025)
Figure 46. Egypt Vaccine Development Service Market Size Growth 2020-2025 ($ millions)
Figure 47. South Africa Vaccine Development Service Market Size Growth 2020-2025 ($ millions)
Figure 48. Israel Vaccine Development Service Market Size Growth 2020-2025 ($ millions)
Figure 49.Turkey Vaccine Development Service Market Size Growth 2020-2025 ($ millions)
Figure 50. GCC Countries Vaccine Development Service Market Size Growth 2020-2025 ($ millions)
Figure 51. Americas Vaccine Development Service Market Size 2026-2031 ($ millions)
Figure 52. APAC Vaccine Development Service Market Size 2026-2031 ($ millions)
Figure 53. Europe Vaccine Development Service Market Size 2026-2031 ($ millions)
Figure 54. Middle East & Africa Vaccine Development Service Market Size 2026-2031 ($ millions)
Figure 55. United States Vaccine Development Service Market Size 2026-2031 ($ millions)
Figure 56. Canada Vaccine Development Service Market Size 2026-2031 ($ millions)
Figure 57. Mexico Vaccine Development Service Market Size 2026-2031 ($ millions)
Figure 58. Brazil Vaccine Development Service Market Size 2026-2031 ($ millions)
Figure 59. China Vaccine Development Service Market Size 2026-2031 ($ millions)
Figure 60. Japan Vaccine Development Service Market Size 2026-2031 ($ millions)
Figure 61. Korea Vaccine Development Service Market Size 2026-2031 ($ millions)
Figure 62. Southeast Asia Vaccine Development Service Market Size 2026-2031 ($ millions)
Figure 63. India Vaccine Development Service Market Size 2026-2031 ($ millions)
Figure 64. Australia Vaccine Development Service Market Size 2026-2031 ($ millions)
Figure 65. Germany Vaccine Development Service Market Size 2026-2031 ($ millions)
Figure 66.France Vaccine Development Service Market Size 2026-2031 ($ millions)
Figure 67. UK Vaccine Development Service Market Size 2026-2031 ($ millions)
Figure 68. Italy Vaccine Development Service Market Size 2026-2031 ($ millions)
Figure 69. Russia Vaccine Development Service Market Size 2026-2031 ($ millions)
Figure 70. Egypt Vaccine Development Service Market Size 2026-2031 ($ millions)
Figure 71. South Africa Vaccine Development Service Market Size 2026-2031 ($ millions)
Figure 72. Israel Vaccine Development Service Market Size 2026-2031 ($ millions)
Figure 73.Turkey Vaccine Development Service Market Size 2026-2031 ($ millions)
Figure 74. Global Vaccine Development Service Market Size Market ShareForecast byType (2026-2031)
Figure 75. Global Vaccine Development Service Market Size Market ShareForecast by Application (2026-2031)
Figure 76. GCC Countries Vaccine Development Service Market Size 2026-2031 ($ millions)
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Vaccine Development Service Market Size (2020-2031)
2.1.2 Vaccine Development Service Market Size CAGR by Region (2020 VS 2024 VS 2031)
2.1.3 World Current & Future Analysis for Vaccine Development Service by Country/Region (2020, 2024 & 2031)
2.2 Vaccine Development Service Segment by Type
2.2.1 Therapeutic
2.2.2 Prophylactic
2.2.3 Other
2.3 Vaccine Development Service Market Size by Type
2.3.1 Vaccine Development Service Market Size CAGR by Type (2020 VS 2024 VS 2031)
2.3.2 Global Vaccine Development Service Market Size Market Share by Type (2020-2025)
2.4 Vaccine Development Service Segment by Application
2.4.1 Enterprise
2.4.2 Government
2.5 Vaccine Development Service Market Size by Application
2.5.1 Vaccine Development Service Market Size CAGR by Application (2020 VS 2024 VS 2031)
2.5.2 Global Vaccine Development Service Market Size Market Share by Application (2020-2025)
3 VACCINE DEVELOPMENT SERVICE MARKET SIZE BY PLAYER
3.1 Vaccine Development Service Market Size Market Share by Player
3.1.1 Global Vaccine Development Service Revenue by Player (2020-2025)
3.1.2 Global Vaccine Development Service Revenue Market Share by Player (2020-2025)
3.2 Global Vaccine Development Service Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 VACCINE DEVELOPMENT SERVICE BY REGION
4.1 Vaccine Development Service Market Size by Region (2020-2025)
4.2 Global Vaccine Development Service Annual Revenue by Country/Region (2020-2025)
4.3 Americas Vaccine Development Service Market Size Growth (2020-2025)
4.4 APAC Vaccine Development Service Market Size Growth (2020-2025)
4.5 Europe Vaccine Development Service Market Size Growth (2020-2025)
4.6 Middle East & Africa Vaccine Development Service Market Size Growth (2020-2025)
5 AMERICAS
5.1 Americas Vaccine Development Service Market Size by Country (2020-2025)
5.2 Americas Vaccine Development Service Market Size by Type (2020-2025)
5.3 Americas Vaccine Development Service Market Size by Application (2020-2025)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Vaccine Development Service Market Size by Region (2020-2025)
6.2 APAC Vaccine Development Service Market Size by Type (2020-2025)
6.3 APAC Vaccine Development Service Market Size by Application (2020-2025)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 EUROPE
7.1 Europe Vaccine Development Service Market Size by Country (2020-2025)
7.2 Europe Vaccine Development Service Market Size by Type (2020-2025)
7.3 Europe Vaccine Development Service Market Size by Application (2020-2025)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Vaccine Development Service by Region (2020-2025)
8.2 Middle East & Africa Vaccine Development Service Market Size by Type (2020-2025)
8.3 Middle East & Africa Vaccine Development Service Market Size by Application (2020-2025)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 GLOBAL VACCINE DEVELOPMENT SERVICE MARKET FORECAST
10.1 Global Vaccine Development Service Forecast by Region (2026-2031)
10.1.1 Global Vaccine Development Service Forecast by Region (2026-2031)
10.1.2 Americas Vaccine Development Service Forecast
10.1.3 APAC Vaccine Development Service Forecast
10.1.4 Europe Vaccine Development Service Forecast
10.1.5 Middle East & Africa Vaccine Development Service Forecast
10.2 Americas Vaccine Development Service Forecast by Country (2026-2031)
10.2.1 United States Market Vaccine Development Service Forecast
10.2.2 Canada Market Vaccine Development Service Forecast
10.2.3 Mexico Market Vaccine Development Service Forecast
10.2.4 Brazil Market Vaccine Development Service Forecast
10.3 APAC Vaccine Development Service Forecast by Region (2026-2031)
10.3.1 China Vaccine Development Service Market Forecast
10.3.2 Japan Market Vaccine Development Service Forecast
10.3.3 Korea Market Vaccine Development Service Forecast
10.3.4 Southeast Asia Market Vaccine Development Service Forecast
10.3.5 India Market Vaccine Development Service Forecast
10.3.6 Australia Market Vaccine Development Service Forecast
10.4 Europe Vaccine Development Service Forecast by Country (2026-2031)
10.4.1 Germany Market Vaccine Development Service Forecast
10.4.2 France Market Vaccine Development Service Forecast
10.4.3 UK Market Vaccine Development Service Forecast
10.4.4 Italy Market Vaccine Development Service Forecast
10.4.5 Russia Market Vaccine Development Service Forecast
10.5 Middle East & Africa Vaccine Development Service Forecast by Region (2026-2031)
10.5.1 Egypt Market Vaccine Development Service Forecast
10.5.2 South Africa Market Vaccine Development Service Forecast
10.5.3 Israel Market Vaccine Development Service Forecast
10.5.4 Turkey Market Vaccine Development Service Forecast
10.6 Global Vaccine Development Service Forecast by Type (2026-2031)
10.7 Global Vaccine Development Service Forecast by Application (2026-2031)
10.7.1 GCC Countries Market Vaccine Development Service Forecast
11 KEY PLAYERS ANALYSIS
11.1 WuXi AppTec
11.1.1 WuXi AppTec Company Information
11.1.2 WuXi AppTec Vaccine Development Service Product Offered
11.1.3 WuXi AppTec Vaccine Development Service Revenue, Gross Margin and Market Share (2020-2025)
11.1.4 WuXi AppTec Main Business Overview
11.1.5 WuXi AppTec Latest Developments
11.2 Charles River Laboratories
11.2.1 Charles River Laboratories Company Information
11.2.2 Charles River Laboratories Vaccine Development Service Product Offered
11.2.3 Charles River Laboratories Vaccine Development Service Revenue, Gross Margin and Market Share (2020-2025)
11.2.4 Charles River Laboratories Main Business Overview
11.2.5 Charles River Laboratories Latest Developments
11.3 Creative Biolabs
11.3.1 Creative Biolabs Company Information
11.3.2 Creative Biolabs Vaccine Development Service Product Offered
11.3.3 Creative Biolabs Vaccine Development Service Revenue, Gross Margin and Market Share (2020-2025)
11.3.4 Creative Biolabs Main Business Overview
11.3.5 Creative Biolabs Latest Developments
11.4 Creative Biostructure
11.4.1 Creative Biostructure Company Information
11.4.2 Creative Biostructure Vaccine Development Service Product Offered
11.4.3 Creative Biostructure Vaccine Development Service Revenue, Gross Margin and Market Share (2020-2025)
11.4.4 Creative Biostructure Main Business Overview
11.4.5 Creative Biostructure Latest Developments
11.5 PPD
11.5.1 PPD Company Information
11.5.2 PPD Vaccine Development Service Product Offered
11.5.3 PPD Vaccine Development Service Revenue, Gross Margin and Market Share (2020-2025)
11.5.4 PPD Main Business Overview
11.5.5 PPD Latest Developments
11.6 Merck
11.6.1 Merck Company Information
11.6.2 Merck Vaccine Development Service Product Offered
11.6.3 Merck Vaccine Development Service Revenue, Gross Margin and Market Share (2020-2025)
11.6.4 Merck Main Business Overview
11.6.5 Merck Latest Developments
11.7 Sartorius
11.7.1 Sartorius Company Information
11.7.2 Sartorius Vaccine Development Service Product Offered
11.7.3 Sartorius Vaccine Development Service Revenue, Gross Margin and Market Share (2020-2025)
11.7.4 Sartorius Main Business Overview
11.7.5 Sartorius Latest Developments
11.8 Eurofins Scientific
11.8.1 Eurofins Scientific Company Information
11.8.2 Eurofins Scientific Vaccine Development Service Product Offered
11.8.3 Eurofins Scientific Vaccine Development Service Revenue, Gross Margin and Market Share (2020-2025)
11.8.4 Eurofins Scientific Main Business Overview
11.8.5 Eurofins Scientific Latest Developments
11.9 Statens Serum Institut
11.9.1 Statens Serum Institut Company Information
11.9.2 Statens Serum Institut Vaccine Development Service Product Offered
11.9.3 Statens Serum Institut Vaccine Development Service Revenue, Gross Margin and Market Share (2020-2025)
11.9.4 Statens Serum Institut Main Business Overview
11.9.5 Statens Serum Institut Latest Developments
11.10 Thermo Fisher Scientific
11.10.1 Thermo Fisher Scientific Company Information
11.10.2 Thermo Fisher Scientific Vaccine Development Service Product Offered
11.10.3 Thermo Fisher Scientific Vaccine Development Service Revenue, Gross Margin and Market Share (2020-2025)
11.10.4 Thermo Fisher Scientific Main Business Overview
11.10.5 Thermo Fisher Scientific Latest Developments
11.11 TRANSVAC
11.11.1 TRANSVAC Company Information
11.11.2 TRANSVAC Vaccine Development Service Product Offered
11.11.3 TRANSVAC Vaccine Development Service Revenue, Gross Margin and Market Share (2020-2025)
11.11.4 TRANSVAC Main Business Overview
11.11.5 TRANSVAC Latest Developments
11.12 Azenta US
11.12.1 Azenta US Company Information
11.12.2 Azenta US Vaccine Development Service Product Offered
11.12.3 Azenta US Vaccine Development Service Revenue, Gross Margin and Market Share (2020-2025)
11.12.4 Azenta US Main Business Overview
11.12.5 Azenta US Latest Developments
12 RESEARCH FINDINGS AND CONCLUSION
LIST OFTABLES
Table 1. Vaccine Development Service Market Size CAGR by Region (2020 VS 2024 VS 2031) & ($ millions)
Table 2. Vaccine Development Service Annual Sales CAGR by Country/Region (2020, 2024 & 2031) & ($ millions)
Table 3. Major Players ofTherapeutic
Table 4. Major Players of Prophylactic
Table 5. Major Players of Other
Table 6. Vaccine Development Service Market Size CAGR byType (2020 VS 2024 VS 2031) & ($ millions)
Table 7. Global Vaccine Development Service Market Size byType (2020-2025) & ($ millions)
Table 8. Global Vaccine Development Service Market Size Market Share byType (2020-2025)
Table 9. Vaccine Development Service Market Size CAGR by Application (2020 VS 2024 VS 2031) & ($ millions)
Table 10. Global Vaccine Development Service Market Size by Application (2020-2025) & ($ millions)
Table 11. Global Vaccine Development Service Market Size Market Share by Application (2020-2025)
Table 12. Global Vaccine Development Service Revenue by Player (2020-2025) & ($ millions)
Table 13. Global Vaccine Development Service Revenue Market Share by Player (2020-2025)
Table 14. Vaccine Development Service Key Players Head office and Products Offered
Table 15. Vaccine Development Service Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
Table 16. New Products and Potential Entrants
Table 17. Mergers & Acquisitions, Expansion
Table 18. Global Vaccine Development Service Market Size by Region (2020-2025) & ($ millions)
Table 19. Global Vaccine Development Service Market Size Market Share by Region (2020-2025)
Table 20. Global Vaccine Development Service Revenue by Country/Region (2020-2025) & ($ millions)
Table 21. Global Vaccine Development Service Revenue Market Share by Country/Region (2020-2025)
Table 22. Americas Vaccine Development Service Market Size by Country (2020-2025) & ($ millions)
Table 23. Americas Vaccine Development Service Market Size Market Share by Country (2020-2025)
Table 24. Americas Vaccine Development Service Market Size byType (2020-2025) & ($ millions)
Table 25. Americas Vaccine Development Service Market Size Market Share byType (2020-2025)
Table 26. Americas Vaccine Development Service Market Size by Application (2020-2025) & ($ millions)
Table 27. Americas Vaccine Development Service Market Size Market Share by Application (2020-2025)
Table 28. APAC Vaccine Development Service Market Size by Region (2020-2025) & ($ millions)
Table 29. APAC Vaccine Development Service Market Size Market Share by Region (2020-2025)
Table 30. APAC Vaccine Development Service Market Size byType (2020-2025) & ($ millions)
Table 31. APAC Vaccine Development Service Market Size by Application (2020-2025) & ($ millions)
Table 32. Europe Vaccine Development Service Market Size by Country (2020-2025) & ($ millions)
Table 33. Europe Vaccine Development Service Market Size Market Share by Country (2020-2025)
Table 34. Europe Vaccine Development Service Market Size byType (2020-2025) & ($ millions)
Table 35. Europe Vaccine Development Service Market Size by Application (2020-2025) & ($ millions)
Table 36. Middle East & Africa Vaccine Development Service Market Size by Region (2020-2025) & ($ millions)
Table 37. Middle East & Africa Vaccine Development Service Market Size byType (2020-2025) & ($ millions)
Table 38. Middle East & Africa Vaccine Development Service Market Size by Application (2020-2025) & ($ millions)
Table 39. Key Market Drivers & Growth Opportunities of Vaccine Development Service
Table 40. Key Market Challenges & Risks of Vaccine Development Service
Table 41. Key IndustryTrends of Vaccine Development Service
Table 42. Global Vaccine Development Service Market SizeForecast by Region (2026-2031) & ($ millions)
Table 43. Global Vaccine Development Service Market Size Market ShareForecast by Region (2026-2031)
Table 44. Global Vaccine Development Service Market SizeForecast byType (2026-2031) & ($ millions)
Table 45. Global Vaccine Development Service Market SizeForecast by Application (2026-2031) & ($ millions)
Table 46. WuXi AppTec Details, CompanyType, Vaccine Development Service Area Served and Its Competitors
Table 47. WuXi AppTec Vaccine Development Service Product Offered
Table 48. WuXi AppTec Vaccine Development Service Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 49. WuXi AppTec Main Business
Table 50. WuXi AppTec Latest Developments
Table 51. Charles River Laboratories Details, CompanyType, Vaccine Development Service Area Served and Its Competitors
Table 52. Charles River Laboratories Vaccine Development Service Product Offered
Table 53. Charles River Laboratories Vaccine Development Service Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 54. Charles River Laboratories Main Business
Table 55. Charles River Laboratories Latest Developments
Table 56. Creative Biolabs Details, CompanyType, Vaccine Development Service Area Served and Its Competitors
Table 57. Creative Biolabs Vaccine Development Service Product Offered
Table 58. Creative Biolabs Vaccine Development Service Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 59. Creative Biolabs Main Business
Table 60. Creative Biolabs Latest Developments
Table 61. Creative Biostructure Details, CompanyType, Vaccine Development Service Area Served and Its Competitors
Table 62. Creative Biostructure Vaccine Development Service Product Offered
Table 63. Creative Biostructure Vaccine Development Service Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 64. Creative Biostructure Main Business
Table 65. Creative Biostructure Latest Developments
Table 66. PPD Details, CompanyType, Vaccine Development Service Area Served and Its Competitors
Table 67. PPD Vaccine Development Service Product Offered
Table 68. PPD Vaccine Development Service Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 69. PPD Main Business
Table 70. PPD Latest Developments
Table 71. Merck Details, CompanyType, Vaccine Development Service Area Served and Its Competitors
Table 72. Merck Vaccine Development Service Product Offered
Table 73. Merck Vaccine Development Service Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 74. Merck Main Business
Table 75. Merck Latest Developments
Table 76. Sartorius Details, CompanyType, Vaccine Development Service Area Served and Its Competitors
Table 77. Sartorius Vaccine Development Service Product Offered
Table 78. Sartorius Vaccine Development Service Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 79. Sartorius Main Business
Table 80. Sartorius Latest Developments
Table 81. Eurofins Scientific Details, CompanyType, Vaccine Development Service Area Served and Its Competitors
Table 82. Eurofins Scientific Vaccine Development Service Product Offered
Table 83. Eurofins Scientific Vaccine Development Service Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 84. Eurofins Scientific Main Business
Table 85. Eurofins Scientific Latest Developments
Table 86. Statens Serum Institut Details, CompanyType, Vaccine Development Service Area Served and Its Competitors
Table 87. Statens Serum Institut Vaccine Development Service Product Offered
Table 88. Statens Serum Institut Vaccine Development Service Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 89. Statens Serum Institut Main Business
Table 90. Statens Serum Institut Latest Developments
Table 91.ThermoFisher Scientific Details, CompanyType, Vaccine Development Service Area Served and Its Competitors
Table 92.ThermoFisher Scientific Vaccine Development Service Product Offered
Table 93.ThermoFisher Scientific Vaccine Development Service Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 94.ThermoFisher Scientific Main Business
Table 95.ThermoFisher Scientific Latest Developments
Table 96.TRANSVAC Details, CompanyType, Vaccine Development Service Area Served and Its Competitors
Table 97.TRANSVAC Vaccine Development Service Product Offered
Table 98.TRANSVAC Vaccine Development Service Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 99.TRANSVAC Main Business
Table 100.TRANSVAC Latest Developments
Table 101. Azenta US Details, CompanyType, Vaccine Development Service Area Served and Its Competitors
Table 102. Azenta US Vaccine Development Service Product Offered
Table 103. Azenta US Vaccine Development Service Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 104. Azenta US Main Business
Table 105. Azenta US Latest Developments
LIST OFFIGURES
Figure 1. Vaccine Development Service Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global Vaccine Development Service Market Size Growth Rate (2020-2031) ($ millions)
Figure 6. Vaccine Development Service Sales by Geographic Region (2020, 2024 & 2031) & ($ millions)
Figure 7. Vaccine Development Service Sales Market Share by Country/Region (2024)
Figure 8. Vaccine Development Service Sales Market Share by Country/Region (2020, 2024 & 2031)
Figure 9. Global Vaccine Development Service Market Size Market Share byType in 2024
Figure 10. Vaccine Development Service in Enterprise
Figure 11. Global Vaccine Development Service Market: Enterprise (2020-2025) & ($ millions)
Figure 12. Vaccine Development Service in Government
Figure 13. Global Vaccine Development Service Market: Government (2020-2025) & ($ millions)
Figure 14. Global Vaccine Development Service Market Size Market Share by Application in 2024
Figure 15. Global Vaccine Development Service Revenue Market Share by Player in 2024
Figure 16. Global Vaccine Development Service Market Size Market Share by Region (2020-2025)
Figure 17. Americas Vaccine Development Service Market Size 2020-2025 ($ millions)
Figure 18. APAC Vaccine Development Service Market Size 2020-2025 ($ millions)
Figure 19. Europe Vaccine Development Service Market Size 2020-2025 ($ millions)
Figure 20. Middle East & Africa Vaccine Development Service Market Size 2020-2025 ($ millions)
Figure 21. Americas Vaccine Development Service Value Market Share by Country in 2024
Figure 22. United States Vaccine Development Service Market Size Growth 2020-2025 ($ millions)
Figure 23. Canada Vaccine Development Service Market Size Growth 2020-2025 ($ millions)
Figure 24. Mexico Vaccine Development Service Market Size Growth 2020-2025 ($ millions)
Figure 25. Brazil Vaccine Development Service Market Size Growth 2020-2025 ($ millions)
Figure 26. APAC Vaccine Development Service Market Size Market Share by Region in 2024
Figure 27. APAC Vaccine Development Service Market Size Market Share byType (2020-2025)
Figure 28. APAC Vaccine Development Service Market Size Market Share by Application (2020-2025)
Figure 29. China Vaccine Development Service Market Size Growth 2020-2025 ($ millions)
Figure 30. Japan Vaccine Development Service Market Size Growth 2020-2025 ($ millions)
Figure 31. South Korea Vaccine Development Service Market Size Growth 2020-2025 ($ millions)
Figure 32. Southeast Asia Vaccine Development Service Market Size Growth 2020-2025 ($ millions)
Figure 33. India Vaccine Development Service Market Size Growth 2020-2025 ($ millions)
Figure 34. Australia Vaccine Development Service Market Size Growth 2020-2025 ($ millions)
Figure 35. Europe Vaccine Development Service Market Size Market Share by Country in 2024
Figure 36. Europe Vaccine Development Service Market Size Market Share byType (2020-2025)
Figure 37. Europe Vaccine Development Service Market Size Market Share by Application (2020-2025)
Figure 38. Germany Vaccine Development Service Market Size Growth 2020-2025 ($ millions)
Figure 39.France Vaccine Development Service Market Size Growth 2020-2025 ($ millions)
Figure 40. UK Vaccine Development Service Market Size Growth 2020-2025 ($ millions)
Figure 41. Italy Vaccine Development Service Market Size Growth 2020-2025 ($ millions)
Figure 42. Russia Vaccine Development Service Market Size Growth 2020-2025 ($ millions)
Figure 43. Middle East & Africa Vaccine Development Service Market Size Market Share by Region (2020-2025)
Figure 44. Middle East & Africa Vaccine Development Service Market Size Market Share byType (2020-2025)
Figure 45. Middle East & Africa Vaccine Development Service Market Size Market Share by Application (2020-2025)
Figure 46. Egypt Vaccine Development Service Market Size Growth 2020-2025 ($ millions)
Figure 47. South Africa Vaccine Development Service Market Size Growth 2020-2025 ($ millions)
Figure 48. Israel Vaccine Development Service Market Size Growth 2020-2025 ($ millions)
Figure 49.Turkey Vaccine Development Service Market Size Growth 2020-2025 ($ millions)
Figure 50. GCC Countries Vaccine Development Service Market Size Growth 2020-2025 ($ millions)
Figure 51. Americas Vaccine Development Service Market Size 2026-2031 ($ millions)
Figure 52. APAC Vaccine Development Service Market Size 2026-2031 ($ millions)
Figure 53. Europe Vaccine Development Service Market Size 2026-2031 ($ millions)
Figure 54. Middle East & Africa Vaccine Development Service Market Size 2026-2031 ($ millions)
Figure 55. United States Vaccine Development Service Market Size 2026-2031 ($ millions)
Figure 56. Canada Vaccine Development Service Market Size 2026-2031 ($ millions)
Figure 57. Mexico Vaccine Development Service Market Size 2026-2031 ($ millions)
Figure 58. Brazil Vaccine Development Service Market Size 2026-2031 ($ millions)
Figure 59. China Vaccine Development Service Market Size 2026-2031 ($ millions)
Figure 60. Japan Vaccine Development Service Market Size 2026-2031 ($ millions)
Figure 61. Korea Vaccine Development Service Market Size 2026-2031 ($ millions)
Figure 62. Southeast Asia Vaccine Development Service Market Size 2026-2031 ($ millions)
Figure 63. India Vaccine Development Service Market Size 2026-2031 ($ millions)
Figure 64. Australia Vaccine Development Service Market Size 2026-2031 ($ millions)
Figure 65. Germany Vaccine Development Service Market Size 2026-2031 ($ millions)
Figure 66.France Vaccine Development Service Market Size 2026-2031 ($ millions)
Figure 67. UK Vaccine Development Service Market Size 2026-2031 ($ millions)
Figure 68. Italy Vaccine Development Service Market Size 2026-2031 ($ millions)
Figure 69. Russia Vaccine Development Service Market Size 2026-2031 ($ millions)
Figure 70. Egypt Vaccine Development Service Market Size 2026-2031 ($ millions)
Figure 71. South Africa Vaccine Development Service Market Size 2026-2031 ($ millions)
Figure 72. Israel Vaccine Development Service Market Size 2026-2031 ($ millions)
Figure 73.Turkey Vaccine Development Service Market Size 2026-2031 ($ millions)
Figure 74. Global Vaccine Development Service Market Size Market ShareForecast byType (2026-2031)
Figure 75. Global Vaccine Development Service Market Size Market ShareForecast by Application (2026-2031)
Figure 76. GCC Countries Vaccine Development Service Market Size 2026-2031 ($ millions)
More Publications
Global Small Size Flexible OLED Panel Market Growth 2025-2031
US$ 3,660.00
November 2025
104 pages
Global Bluetooth Speaker Batteries Market Growth 2024-2030
US$ 3,660.00
June 2024
119 pages
Global Open Frame AC-DC Power Supplies Market Growth 2023-2029
US$ 3,660.00
January 2023
116 pages
Global USB 3.0 Cameras Market Growth (Status and Outlook) 2024-2030
US$ 3,660.00
September 2024
127 pages
Global FPGA Module Market Growth 2023-2029
US$ 3,660.00
February 2023
108 pages
